Biotelemetry alert: bragar eagel & squire, p.c. investigates sale of beat and encourages investors to contact the firm

New york, dec. 18, 2020 (globe newswire) -- bragar eagel & squire, p.c., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of biotelemetry, inc. (nasdaq: beat) breached their fiduciary duties or violated the federal securities laws in connection with the company's acquisition by koninklijke philips n.v. (nyse: phg) (“royal philips”).
BEAT Ratings Summary
BEAT Quant Ranking